<DOC>
	<DOC>NCT01382576</DOC>
	<brief_summary>In the present study, serum chitotriosidase activity and its relationship with insulin resistance were determined in patients with Polycystic Ovary Syndrome (PCOS).</brief_summary>
	<brief_title>Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity</brief_title>
	<detailed_description>ChT activity is increased in patients with PCOS in concordance with insulin resistance. These findings may reflect the pronounced risk for metabolic syndrome and atherosclerotic diseases in this particular patient group.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>Absence of significant abnormalities on physical examination except hirsutism no lipid lowering, hypoglycemic, antihypertensive or hormone replacement therapy normal thyroid function and prolactin level absence of history or evidence of metabolic, cardiovascular, respiratory or hepatic disease Pregnant ovarian tumors congenital adrenal hyperplasia or BMI greater than 30 kg/m2</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>polycystic ovary syndrome</keyword>
	<keyword>chitotriosidase activity</keyword>
</DOC>